throbber
Weeks, Dustin B.
`
`From:
`Sent:
`To:
`
`Subject:
`Attachments:
`
`PRPS SYSTEM NOTIFICATION [PRPS_Trial@uspto.gov]
`Thursday, January 21, 2016 2:25 AM
`jblake@merchantgould.com; mfedowitz@merchantgould.com; Ettinger, Heather; Robinson,
`Joseph R.; Weeks, Dustin B.; Ettinger, Heather
`Party filing notice received - IPR2015-00990
`webwbUSPTOSeal2.gif
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`PATENT TRIAL AND APPEAL BOARD
`
`Filing Courtesy Notice
`
`Please note the following filing:
`
`Case Number:
`Filer:
`Filing Date:
`
`IPR2015-00990
`NPS Pharmaceuticals, Inc. of Bedminster, NJ
`1/21/2016
`
`Type
`
`Exhibit
`
`Document List
`Paper Name
`Transcript of Video
`Deposition of
`Anthony Palmieri
`III, Ph.D.
`CV of John F.
`Carpenter, Ph.D.
`CV of Gordon
`Exhibit
`Rausser, Ph.D.
`Exhibit
`Jackson 2012
`Exhibit
`Onoue 2004
`U.S. Pharmacopeia Exhibit
`
`Exhibit
`
`Paper / Exhibit Number
`
`2042
`
`2043
`
`2044
`2045
`2046
`2047
`
`1
`
`

`
`Exhibit
`Exhibit
`Exhibit
`Exhibit
`Exhibit
`Exhibit
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`24, 774-77 (1999)
`Joshi 2012
`Fang 2012
`Blundell 1983
`Boesch 1978
`Akers 2002
`U.S. Pharmacopeia
`788 (2011)
`Remington 1990
`U.S. Patent
`Publication No.
`2013/0310314
`Annex1 Summary
`of Product
`Characteristics
`Orange Book
`Listing for Gattex Exhibit
`Eli Lilly and Co.
`Exhibit
`(2012)
`Al-Hussein 2013
`Exhibit
`Izutsu 2009
`Exhibit
`U.S. Pharmacopeia
`23, 1650-51 (1995) Exhibit
`Center for Drug
`Evaluation and
`Research,
`Application Number
`203441Orig1s000,
`Chemistry
`Review(s)
`U.S. Food and Drug
`Administration,
`FDA Approved
`Drug Products -
`Zorbtive.
`Shire, Shire
`completes
`acquisition of NPS
`Pharma, February
`21, 2015
`Engellenner 2015
`Walker, Joseph and
`Rob Copeland, New
`Hedge Fund
`Strategy Dispute the
`Patent, Short the
`Stock, Wall Street
`Journal April 7,
`2015
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`2048
`2049
`2050
`2051
`2052
`2053
`2054
`
`2055
`
`2057
`
`2058
`
`2059
`2060
`2061
`2062
`
`2063
`
`2064
`
`2065
`
`2066
`
`2067
`
`2
`
`

`
`Wieczner 2015
`Buchman 2006
`Pirona 2015
`O'Keefe 2006
`Buchman 1997
`NPS 2012 -
`Developing orphan
`products for patients
`Hofstetter 2013
`O'Keefe 2015 -
`Nutritional Issues in
`the SBS
`Tee 2011 -
`Emerging
`Treatment Options
`for SBS - Potential
`Role of Teduglutide
`Naberhuis 2015 -
`Teduglutide for
`Safe Reduction of
`Parenteral Nutrient
`Buchman 2012 -
`Teduglutide and
`SBS
`FDA - Approved
`Drug Products
`Zorbtive
`Crohn's and Colitis
`2013 - Short Bowel
`Syndrome and
`Crohn's Disease
`Donohoe 2010 -
`Short Bowel
`Syndrome
`Zorbtive label
`Wales 2010 -
`Human growth
`hormone and
`glutamine
`Serono 2005 -
`Annual Report
`Part 1 Merck 2013 -
`Annual Report
`Part 2 Merck 2013 -
`Annual Report
`Keller 2004 -
`Management of the
`Short Bowel
`Syndrome after
`
`Exhibit
`Exhibit
`Exhibit
`Exhibit
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`2068
`2069
`2070
`2071
`2072
`
`2073
`
`2074
`
`2076
`
`2077
`
`2078
`
`2079
`
`2080
`
`2081
`
`2082
`
`2083
`
`2084
`
`2085
`
`2086
`
`2086
`
`2087
`
`3
`
`

`
`Extensive Small
`Bowel Resection
`Gattex label
`Oley Foundation
`1994 - North
`American Home
`Parenteral
`NPS 2011 - NPS
`Pharmaceuticals
`Announces
`Completion of
`Treatment Phase in
`STEPS
`Seeking Alpha -
`CEO Discusses Q1
`2013 Results
`Amiot 2013 -
`Determinants of
`home parenteral
`nutrition
`dependence
`McKeage 2015 -
`Teduglutide - A
`Guide to its Use in
`SBS
`FDA 2015 - Orange
`Book Approved
`Drug Products with
`Therapeutic
`Equivalence
`Evaluations
`Jeppesen 2014 -
`Spectrum of short
`bowel syndrome in
`adults - Intestinal
`insufficiency to
`intestinal failure
`AGA 2003 -
`Technical Review
`on Short Bowl
`Syndrome and
`Intestinal
`Transplantation
`Jeppesen 1999 -
`Quality of life in
`patients receiving
`home parenteral
`nutrition
`Jeppesen 2011 -
`Randomised
`
`Exhibit
`
`Exhibit
`
`2088
`
`2089
`
`Exhibit
`
`2090
`
`Exhibit
`
`Exhibit
`
`2091
`
`2092
`
`Exhibit
`
`2093
`
`Exhibit
`
`2094
`
`Exhibit
`
`2095
`
`Exhibit
`
`2096
`
`Exhibit
`
`Exhibit
`
`2097
`
`2098
`
`4
`
`

`
`placebo-controlled
`trial of teduglutide
`in
`ADA 2013 -
`Economic Cost of
`Diabetes in the US
`in 2012
`Rodrigues 2011 -
`Short Bowel
`Syndrome
`Thompson 2012 -
`Current
`Management of
`SBS
`Jeppesen 2012 -
`Teduglutide
`Reduces Need for
`Parenteral Support
`Among Patients
`with SBS
`Seeking Alpha -
`CEO Discusses Q2
`2013 Results
`Seeking Alpha -
`CEO Discusses Q3
`2013 Results
`Seeking Alpha -
`CEO Discusses Q4
`2013 Results
`Shire 2015 - Q3
`2015 Results
`Shire 2015 - Q3
`2015 Results
`Wolters Kluwer
`Price Data
`NPS
`Pharmaceuticals'
`(NPSP) CEO
`Francois Nader on
`Q1 2014 Results -
`Earnings Call
`Transcript
`Seeking Alpha -
`CEO Francois
`Nader on Q2 2014
`Results
`Seeking Alpha -
`CEO Francois
`Nader on Q3 2014
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`2099
`
`2100
`
`2101
`
`Exhibit
`
`2102
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`2103
`
`2104
`
`2105
`
`2106
`
`2107
`
`2108
`
`Exhibit
`
`2109
`
`Exhibit
`
`Exhibit
`
`2110
`
`2111
`
`5
`
`

`
`Results
`NPS 2014 10-K
`Shire 2015 - Q1
`2015 Results
`Shire 2015 - Q2
`2015 results
`Shire 2015 - SHPG
`Flemming Ornskov
`on Q3 2015 Results
`- Earnings Call
`Transcript
`Seeking Alpha 2013
`- NPS
`Pharmaceuticals
`CEO Discusses
`Yahoo Finance -
`NPSP Historical
`Prices
`NPS 2013 10-K
`Moon 2014 -
`Biotech selloff
`could be harbinger
`of further decline
`Reuters
`Ashton 2014 -
`Biotech Sell Off
`Drags NASDAQ-
`100 Down To 2-
`Year Lows
`Nasdaq - Overview
`for NBI
`Yahoo Finance -
`NBI Historical
`Prices
`Yahoo Finance -
`XBI Historical
`Prices
`Shire - Patient
`Assistance Program
`Gattex
`SP Capital IQ 2014
`- NPS
`Pharmaceuticals
`(NPSP)
`Osbourne 2014 -
`Natpara sails
`through panel
`despite headwind
`Shire 2015 - Q1
`
`Exhibit
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`2112
`2113
`
`2114
`
`2115
`
`2116
`
`2117
`
`2118
`
`2119
`
`2120
`
`2121
`
`2122
`
`2123
`
`2124
`
`2125
`
`2126
`
`2127
`
`6
`
`

`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`2015 10-Q
`FDA 2015 -
`Expiration Dating
`and Stability
`Testing for Human
`Gibson 2009 -
`Pharmaceutical
`Preformulation and
`Formulation
`Cohen 2000 - Many
`medicines are
`potent years past
`expiration dates
`Merck 2014 -
`Annual Report
`FDA CDER - Initial
`Quality Assessment Exhibit
`Herper 2012 -
`Inside The Secret
`World Of Drug
`Company Rebates -
`Forbes
`Shire - Sharps
`Disposal Gattex
`Shire - OnePath
`Support Program Exhibit
`Klick Health -
`Patient Support
`Programs
`FDA 2014 -
`Guidance on
`Devices for Home
`Use
`FDA - Approved
`Drug Products
`Gattex
`Adempas (riociguat)
`- Aim Patient
`Support Program
`Overview
`Celgene - Patient
`Support
`Merck 2006 -
`Annual Report
`Merck 2007 -
`Annual Report
`Merck 2008 -
`Annual Report
`Merck 2009 -
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`Exhibit
`
`2128
`
`2129
`
`2130
`
`2131
`
`2132
`
`2133
`
`2134
`
`2135
`
`2136
`
`2137
`
`2138
`
`2139
`
`2140
`
`2141
`
`2142
`
`2143
`2144
`
`7
`
`

`
`Annual Report
`Part 1 Merck 2010 -
`Annual Report
`Part 2 Merck 2010 -
`Annual Report
`Part 1 Merck 2011 -
`Annual Report
`Merck 2012 -
`Annual Report
`Part 2 Merck 2011 -
`Annual Report
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`Exhibit
`
`2145
`
`2145
`
`2146
`
`2147
`
`2146
`
`Questions regarding this receipt should be directed to the Patent Trial and Appeal Board at 571-272-7822.
`This e-mail is computer-generated. Do not reply because this e-mail address is not monitored.
`
`8

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket